These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 28645834)

  • 1. Left Ventricular Assist Device Therapy for Destination Therapy: Is Less Invasive Surgery a Safe Alternative?
    Rojas SV; Hanke JS; Avsar M; Ahrens PR; Deutschmann O; Tümler KA; Uribarri A; Rojas-Hernández S; Sánchez PL; González-Santos JM; Haverich A; Schmitto JD
    Rev Esp Cardiol (Engl Ed); 2018 Jan; 71(1):13-17. PubMed ID: 28645834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Less invasive surgical implant strategy and right heart failure after LVAD implantation.
    Saeed D; Muslem R; Rasheed M; Caliskan K; Kalampokas N; Sipahi F; Lichtenberg A; Jawad K; Borger M; Huhn S; Cogswell R; John R; Schultz J; Shah H; Hsu S; Gilotra NA; Scheel PJ; Tomashitis B; Hajj ME; Lozonschi L; Houston BA; Tedford RJ
    J Heart Lung Transplant; 2021 Apr; 40(4):289-297. PubMed ID: 33509653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study results suggest less invasive HeartMate 3 implantation is a safe and effective approach for obese patients.
    Bjelic M; Ayers B; Paic F; Bernstein W; Barrus B; Chase K; Gu Y; Alexis JD; Vidula H; Cheyne C; Prasad S; Gosev I
    J Heart Lung Transplant; 2021 Sep; 40(9):990-997. PubMed ID: 34229916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First results of HeartWare left ventricular assist device implantation with tunnelling of the outflow graft through the transverse sinus.
    Hanke JS; Rojas SV; Cvitkovic T; Wiegmann B; Horke A; Warnecke G; Haverich A; Schmitto JD
    Interact Cardiovasc Thorac Surg; 2017 Oct; 25(4):503-508. PubMed ID: 28962493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Age on Outcomes After Destination-Therapy Left Ventricular Assist Device Implantation: An Analysis of the IMACS Registry.
    Aleksova N; Alba AC; Fan CS; Amin F; Kiamanesh O; McGuinty C; Lee H; Duero Posada JG; Ross HJ; Billia F; Rao V
    Can J Cardiol; 2021 Mar; 37(3):467-475. PubMed ID: 32585330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantation of a fully magnetically levitated left ventricular assist device using a sternal-sparing surgical technique.
    Gosev I; Wood K; Ayers B; Barrus B; Knight P; Alexis JD; Vidula H; Lander H; Wyrobek J; Cheyne C; Goldenberg I; McNitt S; Prasad S
    J Heart Lung Transplant; 2020 Jan; 39(1):37-44. PubMed ID: 31636043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9-Year Experience.
    Morgan JA; Go PH; Xuereb L; Kaur B; Akrawe S; Nemeh HW; Borgi J; Lanfear DE; Williams CT; Paone G
    Ann Thorac Surg; 2016 Oct; 102(4):1266-73. PubMed ID: 27173072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity as a Risk Factor for Consideration for Left Ventricular Assist Devices.
    Mohamedali B; Yost G; Bhat G
    J Card Fail; 2015 Oct; 21(10):800-5. PubMed ID: 26093334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Less Invasive Left Ventricular Assist Device Implantation on Heart Transplant Outcomes.
    Riebandt J; Wiedemann D; Sandner S; Angleitner P; Zuckermann A; Schlöglhofer T; Laufer G; Zimpfer D
    Semin Thorac Cardiovasc Surg; 2022; 34(1):148-156. PubMed ID: 33609672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical correction of aortic valve insufficiency after left ventricular assist device implantation.
    Atkins BZ; Hashmi ZA; Ganapathi AM; Harrison JK; Hughes GC; Rogers JG; Milano CA
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1247-52. PubMed ID: 23870154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative renal dysfunction does not affect outcomes of left ventricular assist device implantation.
    Kilic A; Chen CW; Gaffey AC; Wald JW; Acker MA; Atluri P
    J Thorac Cardiovasc Surg; 2018 Sep; 156(3):1093-1101.e1. PubMed ID: 30017440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
    Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH
    J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of surgical approach for left ventricular assist device implantation on postoperative invasive hemodynamics and right ventricular failure.
    Bjelic M; Vidula H; Wu IY; McNitt S; Barrus B; Cheyne C; Chase K; Zottola Z; Alexis JD; Goldenberg I; Gosev I
    J Card Surg; 2022 Oct; 37(10):3072-3081. PubMed ID: 35842802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late right heart failure during support with continuous-flow left ventricular assist devices adversely affects post-transplant outcome.
    Takeda K; Takayama H; Colombo PC; Jorde UP; Yuzefpolskaya M; Fukuhara S; Mancini DM; Naka Y
    J Heart Lung Transplant; 2015 May; 34(5):667-74. PubMed ID: 25577566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.